AAAAAA

   
Results: 1-19 |
Results: 19

Authors: Rimmelzwaan, GF Baars, M van Amerongen, G van Beek, R Osterhaus, ADME
Citation: Gf. Rimmelzwaan et al., A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses, VACCINE, 20(1-2), 2001, pp. 158-163

Authors: de Jong, JC Heinen, PP Loeffen, WLA van Nieuwstadt, AP Claas, ECJ Bestebroer, TM Bijlsma, K Verweij, C Osterhaus, ADME Rimmelzwaan, GF Fouchier, RAM Kimman, TG
Citation: Jc. De Jong et al., Antigenic and molecular heterogeneity in recent swine influenza A(H1N1) virus isolates with possible implications for vaccination policy, VACCINE, 19(31), 2001, pp. 4452-4464

Authors: Rimmelzwaan, GF de Jong, JC Bestebroer, TM van Loon, AM Claas, ECJ Fouchier, RAM Osterhaus, ADM
Citation: Gf. Rimmelzwaan et al., Antigenic and genetic characterization of swine influenza A (H1N1) virusesisolated from pneumonia patients in the Netherlands, VIROLOGY, 282(2), 2001, pp. 301-306

Authors: Rimmelzwaan, GF Kuiken, T van Amerongen, G Bestebroer, TM Fouchier, RAM Osterhaus, ADME
Citation: Gf. Rimmelzwaan et al., Pathogenesis of influenza A (H5N1) virus infection in a primate model, J VIROLOGY, 75(14), 2001, pp. 6687-6691

Authors: Voeten, JTM Rimmelzwaan, GF Nieuwkoop, NJ Fouchier, RAM Osterhaus, ADME
Citation: Jtm. Voeten et al., Antigen processing for MHC class I restricted presentation of exogenous influenza A virus nucleoprotein by B-lymphoblastoid cells, CLIN EXP IM, 125(3), 2001, pp. 423-431

Authors: Rimmelzwaan, GF Nieuwkoop, N Brandenburg, A Sutter, G Beyer, WEP Maher, D Bates, J Osterhaus, ADME
Citation: Gf. Rimmelzwaan et al., A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM (TM) vaccines and conventional vaccines, VACCINE, 19(9-10), 2000, pp. 1180-1187

Authors: Voeten, JTM Rimmelzwaan, GF Nieuwkoop, NJ Lovgren-Bengtsson, K Osterhaus, ADME
Citation: Jtm. Voeten et al., Introduction of the haemagglutinin transmembrane region in the influenza virus matrix protein facilitates its incorporation into ISCOM and activationof specific CD8(+) cytotoxic T lymphocytes, VACCINE, 19(4-5), 2000, pp. 514-522

Authors: de Jong, JC Rimmelzwaan, GF Fouchier, RAM Osterhaus, ADME
Citation: Jc. De Jong et al., Influenza virus: a master of metamorphosis, J INFECTION, 40(3), 2000, pp. 218-228

Authors: Soesman, NMR Rimmelzwaan, GF Nieuwkoop, NJ Beyer, WEP Tilanus, HW Kemmeren, MH Metselaar, HJ de Man, RA Osterhaus, ADME
Citation: Nmr. Soesman et al., Efficacy of influenza vaccination in adult liver transplant recipients, J MED VIROL, 61(1), 2000, pp. 85-93

Authors: de Jong, JC Beyer, WEP Palache, AM Rimmelzwaan, GF Osterhaus, ADME
Citation: Jc. De Jong et al., Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly, J MED VIROL, 61(1), 2000, pp. 94-99

Authors: Fouchier, RAM Bestebroer, TM Herfst, S Van der Kemp, L Rimmelzwaan, GF Osterhaus, ADME
Citation: Ram. Fouchier et al., Detection of influenza A viruses from different species by PCR amplification of conserved sequences in the matrix gene, J CLIN MICR, 38(11), 2000, pp. 4096-4101

Authors: Barnett, JM Cadman, A Gor, D Dempsey, M Walters, M Candlin, A Tisdale, M Morley, PJ Owens, IJ Fenton, RJ Lewis, AP Claas, ECJ Rimmelzwaan, GF De Groot, R Osterhaus, ADME
Citation: Jm. Barnett et al., Zanamivir susceptibility monitoring and characterization of influenza virus clinical isolates obtained during phase II clinical efficacy studies, ANTIM AG CH, 44(1), 2000, pp. 78-87

Authors: Osterhaus, ADME Rimmelzwaan, GF Martina, BEE Bestebroer, TM Fouchier, RAM
Citation: Adme. Osterhaus et al., Influenza B virus in seals, SCIENCE, 288(5468), 2000, pp. 1051-1053

Authors: Voeten, JTM Bestebroer, TM Nieuwkoop, NJ Fouchier, RAM Osterhaus, ADME Rimmelzwaan, GF
Citation: Jtm. Voeten et al., Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes, J VIROLOGY, 74(15), 2000, pp. 6800-6807

Authors: Rimmelzwaan, GF Baars, M van Beek, R de Lijster, P de Jong, JC Claas, ECJ Osterhaus, ADME
Citation: Gf. Rimmelzwaan et al., Influenza virus subtype cross-reactivities of haemagglutination inhibitingand virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine, VACCINE, 17(20-21), 1999, pp. 2512-2516

Authors: Voeten, JTM Brands, R Palache, AM van Scharrenburg, GJM Rimmelzwaan, GF Osterhaus, ADME Claas, ECJ
Citation: Jtm. Voeten et al., Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium, VACCINE, 17(15-16), 1999, pp. 1942-1950

Authors: Rimmelzwaan, GF Claas, ECJ van Amerongen, G de Jong, JC Osterhaus, ADME
Citation: Gf. Rimmelzwaan et al., ISCOM vaccine induced protection against a lethal challenge with a human H5N1 influenza virus, VACCINE, 17(11-12), 1999, pp. 1355-1358

Authors: Rimmelzwaan, GF Baars, MMJW de Lijster, P Fouchier, RAM Osterhaus, ADME
Citation: Gf. Rimmelzwaan et al., Inhibition of influenza virus replication by nitric oxide, J VIROLOGY, 73(10), 1999, pp. 8880-8883

Authors: Karlas, JA Siebelink, KHJ van Peer, MA Huisman, W Cuisinier, AM Rimmelzwaan, GF Osterhaus, ADME
Citation: Ja. Karlas et al., Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challengeinfection, J GEN VIROL, 80, 1999, pp. 761-765
Risultati: 1-19 |